相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer
Daniel E. Spratt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1, and androgen receptor
Masaki Shiota et al.
PROSTATE (2013)
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer
Ronald C. Chen et al.
BJU INTERNATIONAL (2012)
High-Risk Prostate Cancer: From Definition to Contemporary Management
Patrick J. Bastian et al.
EUROPEAN UROLOGY (2012)
LONG-TERM FOLLOW-UP OF A PROSPECTIVE TRIAL OF TRIMODALITY THERAPY OF WEEKLY PACLITAXEL, RADIATION, AND ANDROGEN DEPRIVATION IN HIGH-RISK PROSTATE CANCER WITH OR WITHOUT PRIOR PROSTATECTOMY
Arif Hussain et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy
Jochen Walz et al.
BJU INTERNATIONAL (2011)
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial
Michel Bolla et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Does Hormone Treatment Added to Radiotherapy Improve Outcome in Locally Advanced Prostate Cancer? Meta-Analysis of Randomized Trials
Emilio Bria et al.
CANCER (2009)
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991
O. Matzinger et al.
EUROPEAN JOURNAL OF CANCER (2009)
A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer
Edwin A. Alvarez et al.
GYNECOLOGIC ONCOLOGY (2009)
HIGHER-THAN-CONVENTIONAL RADIATION DOSES IN LOCALIZED PROSTATE CANCER TREATMENT: A META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
Gustavo Arruda Viani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
Ofer Yossepowitch et al.
EUROPEAN UROLOGY (2008)
Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer
Nicholas J. Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
Eric M. Horwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intensity-modulated radiation therapy: Supportive data for prostate cancer
Oren Cahlon et al.
SEMINARS IN RADIATION ONCOLOGY (2008)
Phase I/II trial of docetaxel and concurrent radiation therapy in localized high risk prostate cancer (AGUSG 03-10)
Michael Perrotti et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate
P Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
P Bader et al.
JOURNAL OF UROLOGY (2003)
分享论文
